Development of tablets containing semipurified extract of guaraná (Paullinia cupana)
AUTOR(ES)
Klein, Traudi, Longhini, Renata, Bruschi, Marcos Luciano, Mello, João Carlos Palazzo de
FONTE
Rev. bras. farmacogn.
DATA DE PUBLICAÇÃO
14/12/2012
RESUMO
This study evaluated the technological feasibility of producing a semipurified extract of guaraná (Paullinia cupana Kunth, Sapindaceae) in tablet form, using a direct-compression process. Maltodextrin and gum arabic were used to produce the extract microparticles, in order to protect the microparticles against such factors as temperature, oxidation, and humidity. Using pharmacopoeial methodologies, technological and physicochemistry tests (determination of residual moisture, of bulk and tapped density, Hausner ratio, compressibility and compactibility index, appearance, mean weight, hardness, friability, disintegration time, determination of EPA amount in tablets and in vitro release profile) were conducted. The formulation containing 200 mg of microparticles, 170 mg microcrystalline cellulose, and 10 mg lactose gave the best results in terms of hardness (116 N), friabilility (0.28%), mean weight (0.3821 g), and disintegration time (25 min) for a tablet designed for oral administration. The results met pharmacopoeial specifications, and the tablets are suitable for oral administration.
Documentos Relacionados
- Determinação de hidrocarbonetos policíclicos aromáticos (HPAS) em guaraná em pó (Paullinia cupana)
- Mechanisms involved in anti-aging effects of guarana (Paullinia cupana) in Caenorhabditis elegans
- Contribuição do guaraná em pó (Paullinia cupana) como fonte de cafeína na dieta
- Effects of the association of cadmium chloride and guarana (Paullinia cupana) on the testis of wistar rats : morphometry, structure and ultrastructure
- Fluid bed drying of guarana (Paullinia cupana HBK) extract: Effect of process factors on caffeine content